Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Shares Issued: 2014-2017

Historic Shares Issued for Soleno Therapeutics (SLNO) over the last 1 years, with Mar 2017 value amounting to $10.0 million.

  • Soleno Therapeutics' Shares Issued was N/A to $10.0 million in Q1 2017 from the same period last year, while for Mar 2017 it was $10.1 million, marking a year-over-year change of. This contributed to the annual value of $149.0 million for FY2024, which is 42826.51% up from last year.
  • As of Q1 2017, Soleno Therapeutics' Shares Issued stood at $10.0 million, which was up 9,803,821.57% from $102 recorded in Q4 2016.
  • Over the past 5 years, Soleno Therapeutics' Shares Issued peaked at $10.7 million during Q4 2014, and registered a low of $102 during Q4 2016.
  • Moreover, its 3-year median value for Shares Issued was $70,000 (2016), whereas its average is $1.6 million.
  • Data for Soleno Therapeutics' Shares Issued shows a maximum YoY slumped of 100.00% (in 2015) over the last 5 years.
  • Over the past 4 years, Soleno Therapeutics' Shares Issued (Quarterly) stood at $10.7 million in 2014, then slumped by 100.00% to $194 in 2015, then plummeted by 47.42% to $102 in 2016, then reached $10.0 million in 2017.
  • Its Shares Issued was $10.0 million in Q1 2017, compared to $102 in Q4 2016 and $70,000 in Q2 2016.